Shanghai Pharmaceuticals Holding Co(HK:2607)
HK$11.02+0.15 (+1.38%)
HK:2607
Shanghai Pharmaceuticals Holding Co financials statements
HK$11.02
At close:+0.15 (+1.38%)
Want to see HK:2607 full AI Analyst Report?
Shanghai Pharmaceuticals Holding Co (2607) Financial Statements
5 Followers
Shanghai Pharmaceuticals Holding Co Financial Overview
Shanghai Pharmaceuticals Holding Co's market cap is currently ¥64.31B. The company's EPS TTM is ¥1.38; its P/E ratio is 11.88; and it has a dividend yield of 5.93%. Shanghai Pharmaceuticals Holding Co is estimated to report earnings on April 1, 2027, and the estimated EPS forecast is ¥0.32. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 283.58B | ¥ 275.25B | ¥ 260.30B | ¥ 231.98B | ¥ 215.82B |
| Gross Profit | ¥ 30.42B | ¥ 30.63B | ¥ 30.93B | ¥ 30.49B | ¥ 28.54B |
| Operating Income | ¥ 9.94B | ¥ 8.14B | ¥ 7.67B | ¥ 9.01B | ¥ 8.21B |
| EBITDA | ¥ 14.37B | ¥ 12.06B | ¥ 10.90B | ¥ 12.44B | ¥ 10.55B |
| Net Income | ¥ 5.72B | ¥ 4.55B | ¥ 3.77B | ¥ 5.62B | ¥ 5.09B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 43.08B | ¥ 44.38B | ¥ 40.67B | ¥ 37.01B | ¥ 22.39B |
| Total Assets | ¥ 233.15B | ¥ 221.21B | ¥ 211.97B | ¥ 198.13B | ¥ 163.44B |
| Total Debt | ¥ 49.48B | ¥ 47.79B | ¥ 42.90B | ¥ 38.56B | ¥ 31.69B |
| Net Debt | ¥ 16.76B | ¥ 12.05B | ¥ 12.38B | ¥ 11.16B | ¥ 9.30B |
| Total Liabilities | ¥ 143.36B | ¥ 137.47B | ¥ 131.65B | ¥ 120.13B | ¥ 104.37B |
| Stockholders' Equity | ¥ 75.89B | ¥ 71.68B | ¥ 68.52B | ¥ 67.06B | ¥ 49.36B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 3.83B | ¥ 3.43B | ¥ 2.26B | ¥ 2.06B | ¥ 942.55M |
| Operating Cash Flow | ¥ 6.15B | ¥ 5.83B | ¥ 5.23B | ¥ 4.74B | ¥ 5.06B |
| Investing Cash Flow | ¥ -3.98B | ¥ 415.98M | ¥ -2.49B | ¥ -12.47B | ¥ -6.02B |
| Financing Cash Flow | ¥ -5.65B | ¥ -1.86B | ¥ 231.85M | ¥ 12.14B | ¥ 1.57B |
Currency in CNY

